Takeda, Lilly lose bid to overturn $9 billion award for hiding cancer risk

August 29, 2014 2:15 AM

5 0

Takeda, Lilly lose bid to overturn $9 billion award for hiding cancer risk

(Reuters) - Takeda Pharmaceuticals and Eli Lilly & Co lost a bid to overthrow a combined $9 billion punitive-damage award by a U.S. jury for hiding cancer risks associated with their Actos diabetes drug, according to a court ruling.

"Plaintiffs have pointed to sufficient evidence from which the jury could have concluded that the 'information' about bladder cancer contained in Actos labels did not adequately warn of the increased risk of cancer," said U.S. District Judge Rebecca Doherty of the Western District of Louisiana on We...

Read more

To category page

Loading...